Cargando…
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is characterized by inflammatory lung injury, progressive parenchymal stiffening and consolidation, alveolar and airway collapse, altered vascular permeability, diffuse alveolar damage, and surfactant deficiency. COVID-19 cau...
Autores principales: | Ruaro, Barbara, Confalonieri, Paola, Pozzan, Riccardo, Tavano, Stefano, Mondini, Lucrezia, Baratella, Elisa, Pagnin, Alessandra, Lerda, Selene, Geri, Pietro, Biolo, Marco, Confalonieri, Marco, Salton, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267619/ https://www.ncbi.nlm.nih.gov/pubmed/35806862 http://dx.doi.org/10.3390/jcm11133577 |
Ejemplares similares
-
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
por: Ruaro, Barbara, et al.
Publicado: (2022) -
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
por: Ruaro, Barbara, et al.
Publicado: (2022) -
Host-Based Treatments for Severe COVID-19
por: Mondini, Lucrezia, et al.
Publicado: (2023) -
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy
por: Mondini, Lucrezia, et al.
Publicado: (2023) -
Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
por: Salton, Francesco, et al.
Publicado: (2020)